What is the management approach for a 68-year-old male with asymptomatic microscopic hematuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Asymptomatic Microscopic Hematuria in a 68-Year-Old Male

A 68-year-old male with asymptomatic microscopic hematuria requires a complete urologic evaluation including cystoscopy and upper tract imaging due to his high-risk status for urologic malignancy.

Initial Assessment

  • Confirm microscopic hematuria by microscopic examination of urinary sediment (≥3 red blood cells per high-power field on 2 of 3 properly collected specimens) as dipstick positivity alone has limited specificity 1
  • Exclude benign causes including vigorous exercise, sexual activity, viral illness, trauma, and infection 1
  • Assess for signs of primary renal disease:
    • Significant proteinuria (>1,000 mg/24 hours or >500 mg/24 hours if persistent) 1
    • Dysmorphic red blood cells or red cell casts 1
    • Elevated serum creatinine 1

Risk Stratification

  • This patient is high-risk for urologic malignancy due to:
    • Age >40 years (68 years old) 1, 2
    • Male sex 2
    • The prevalence of asymptomatic microscopic hematuria in older men can be as high as 21%, with higher risk for significant urologic disease 1, 2

Evaluation Algorithm

If signs of primary renal disease are present:

  • Refer to nephrology for evaluation of glomerular disease 1

If no signs of primary renal disease (most likely scenario):

  • Complete urologic evaluation is required due to high-risk status 1, 2:
    • Upper tract imaging (CT urography preferred) 2
    • Cystoscopy (complete visualization of bladder mucosa, urethra, and ureteral orifices) 1
    • Urinary cytology (especially for high-risk patients) 1

Cystoscopy Considerations

  • Cystoscopy is recommended in all patients >40 years of age, even if upper tract imaging reveals a potentially benign source for bleeding 1
  • Initial diagnostic cystoscopy can be performed under local anesthesia using flexible cystoscopy, which causes less pain and has equivalent or superior diagnostic accuracy compared to rigid cystoscopy 1

Follow-Up Recommendations

  • For patients with a negative initial evaluation:
    • Repeat urinalysis, urine cytology, and blood pressure determination at 6,12,24, and 36 months 1, 3
    • Additional evaluation (repeat imaging and cystoscopy) may be warranted if hematuria persists and there is high suspicion for underlying disease 1
    • Immediate urologic reevaluation if any of the following occur: gross hematuria, abnormal urinary cytology, or irritative voiding symptoms in the absence of infection 1
    • If none of these occurs within three years, no further urologic monitoring is required 1

Common Pitfalls to Avoid

  • Do not assume hematuria is due to benign prostatic hyperplasia without proper evaluation 3, 4
  • Do not rely solely on dipstick testing without microscopic confirmation 1, 2
  • Do not defer evaluation in high-risk patients, as early detection of urologic malignancy significantly impacts mortality and morbidity 2, 4
  • Do not omit cystoscopy even if upper tract imaging is normal 1
  • Primary care physicians often do not fully evaluate hematuria according to guidelines, which may lead to missed diagnoses 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation of Microscopic Hematuria in High-Risk Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Persistent Microscopic Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hematuria.

Primary care, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.